{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:15:26Z","timestamp":1778559326782,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001631","name":"University College Dublin","doi-asserted-by":"publisher","award":["82934-NP\/R27885"],"award-info":[{"award-number":["82934-NP\/R27885"]}],"id":[{"id":"10.13039\/501100001631","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["312926\/2020-0"],"award-info":[{"award-number":["312926\/2020-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003758","name":"FAPEMA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003758","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejps.2025.107231","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T06:45:02Z","timestamp":1754635502000},"page":"107231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Preparation and characterization of a secnidazole-mandelic acid coamorphous system: enhanced dissolution profile, antibacterial properties, and theoretical druglikeness assessment"],"prefix":"10.1016","volume":"213","author":[{"given":"Jo\u00e3o G.","family":"de Oliveira Neto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana B.N.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayslla C.","family":"Moura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jailton R.","family":"Viana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateus R.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9737-6017","authenticated-orcid":false,"given":"Eliana B.","family":"Souto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossano","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adenilson O.","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107231_bib0001","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/cryst11040328","article-title":"Weak interactions in cocrystals of isoniazid with glycolic and mandelic acids","volume":"11","author":"\u00c1lvarez-Vidaurre","year":"2021","journal-title":"Crystals"},{"key":"10.1016\/j.ejps.2025.107231_bib0002","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107231_bib0003","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jpba.2004.08.008","article-title":"ICH guidance in practice: establishment of inherent stability of secnidazole and development of a validated stability-indicating high-performance liquid chromatographic assay method","volume":"36","author":"Bakshi","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2025.107231_bib0004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2017.03.003","article-title":"Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design","volume":"117","author":"Berry","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107231_bib0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.vibspec.2016.06.007","article-title":"Phase transitions in secnidazole: thermal stability and polymorphism studied by X-ray powder diffraction, thermal analysis and vibrational spectroscopy","volume":"86","author":"Bezerra","year":"2016","journal-title":"Vib. Spectrosc."},{"key":"10.1016\/j.ejps.2025.107231_bib0006","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1021\/acs.chemrev.1c00987","article-title":"Crystal engineering of pharmaceutical cocrystals in the discovery and development of improved drugs","volume":"122","author":"Bolla","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejps.2025.107231_bib0007","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0014-827X(00)00096-3","article-title":"Physico-chemical and solid-state characterization of secnidazole","volume":"55","author":"Boza Rivera","year":"2000","journal-title":"Il Farmaco."},{"key":"10.1016\/j.ejps.2025.107231_bib0008","doi-asserted-by":"crossref","first-page":"7279","DOI":"10.1021\/jp401626a","article-title":"Pressure effect on d,l-mandelic acid racemate crystallization","volume":"117","author":"Cai","year":"2013","journal-title":"J. Physic. Chem. C."},{"key":"10.1016\/j.ejps.2025.107231_bib0009","doi-asserted-by":"crossref","first-page":"34032","DOI":"10.1039\/D3RA05388A","article-title":"New polymorphic phase of arachidic acid crystal: structure, intermolecular interactions, low-temperature stability and Raman spectroscopy combined with DFT calculations","volume":"13","author":"Cardoso","year":"2023","journal-title":"RSC Adv"},{"key":"10.1016\/j.ejps.2025.107231_bib0010","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1039\/b810189b","article-title":"Long-range corrected hybrid density functionals with damped atom\u2013atom dispersion corrections","volume":"10","author":"Chai","year":"2008","journal-title":"Physic. Chem. Chemic. Physics"},{"key":"10.1016\/j.ejps.2025.107231_bib0011","unstructured":"Chemcraft, 2020. Graphical software for visualization of quantum chemistry computations, https:\/\/www.chemcraftprog.com\/(accessed on 21st January 2025)."},{"key":"10.1016\/j.ejps.2025.107231_bib0012","series-title":"Performance Standards for Antimicrobial Susceptibility Testing, 34th ed.; CLSI Supplement M100","year":"2024"},{"key":"10.1016\/j.ejps.2025.107231_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2025.107231_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125159","article-title":"A new coamorphous ethionamide with enhanced solubility: preparation, characterization, in silico pharmacokinetics, and controlled release by encapsulation","volume":"670","author":"De Oliveira Neto","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107231_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2021.111658","article-title":"Structural, thermal, electronic, vibrational, magnetic, and cytotoxic properties of chloro(glycinato-N,O)(1,10-phenanthroline-N,N\u2032)\u2011copper(II) trihydrate coordination complex","volume":"226","author":"De Oliveira Neto","year":"2022","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejps.2025.107231_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.124846","article-title":"Antibacterial [Zn(nicotinamide)2Cl2] complex for the treatment of skin conditions: an experimental-theoretical study of physicochemical, microbiological and in silico pharmacokinetic properties","volume":"403","author":"De Oliveira Neto","year":"2024","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejps.2025.107231_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138835","article-title":"Crystallographic, intermolecular interactions, vibrational, and computational studies of a new cocrystal of decanoic acid and nicotinamide","volume":"1315","author":"De Oliveira Neto","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejps.2025.107231_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2023.121658","article-title":"Synthesis, physicochemical properties, and antitumor cytotoxic activity of the Mg(II) coordination complex containing 1,10-phenanthroline and sulfate ligands","volume":"556","author":"De Oliveira Neto","year":"2023","journal-title":"Inorganica Chim. Acta."},{"key":"10.1016\/j.ejps.2025.107231_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.poly.2024.117234","article-title":"Dichloro-bis(theophylline)-copper(II) complex: characterization of the physicochemical, computational pharmacokinetics, molecular docking, and cytotoxicity as potential antitumoral medicine","volume":"264","author":"de Oliveira Neto","year":"2024","journal-title":"Polyhedron"},{"key":"10.1016\/j.ejps.2025.107231_bib0020","series-title":"GaussView, Version 6, Dennington, Roy; Keith, Todd A.; Millam, John M","author":"Dennington","year":"2016"},{"key":"10.1016\/j.ejps.2025.107231_bib0021","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1021\/acs.jced.8b01001","article-title":"Experimental solubility and density functional theory studies of Deferasirox in binary solvent mixtures: performance of polarizable continuum model and Jouyban\u2013Acree model","volume":"64","author":"Fathi Azarbayjani","year":"2019","journal-title":"J. Chemic. Eng. Data."},{"key":"10.1016\/j.ejps.2025.107231_bib0022","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijpharm.2013.04.032","article-title":"Coamorphous repaglinide\u2013saccharin with enhanced dissolution","volume":"450","author":"Gao","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107231_bib0023","series-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for human use","article-title":"Stability testing of new drug substances and products. ICH harmonised Tripartite guideline, endorsed by the ICH Steering Committee at step 4 of the ICH Process","year":"1993"},{"key":"10.1016\/j.ejps.2025.107231_bib0024","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejpb.2016.06.020","article-title":"Influence of variation in molar ratio on co-amorphous drug-amino acid systems","volume":"107","author":"Jensen","year":"2016","journal-title":"Europe. J. Pharmaceut. Biopharmaceut."},{"key":"10.1016\/j.ejps.2025.107231_bib0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.2042-7158.1975.tb09378.x","article-title":"The concept of dissolution efficiency","volume":"27","author":"Khan","year":"1975","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107231_bib0026","first-page":"48","article-title":"Toward a generic approach for stress testing of drug substances and drug products","volume":"2","author":"Klick","year":"2005","journal-title":"Pharmaceutic. Technol."},{"key":"10.1016\/j.ejps.2025.107231_bib0027","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: a multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejps.2025.107231_bib0028","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1021\/acs.cgd.5b01700","article-title":"Enhanced bioavailability in the oxalate salt of the anti-tuberculosis drug ethionamide","volume":"16","author":"Mannava","year":"2016","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2025.107231_bib0029","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1021\/jp411738p","article-title":"Wallach\u2019s rule enforced by pressure in mandelic acid","volume":"118","author":"Marciniak","year":"2014","journal-title":"J. Physic. Chem. C."},{"key":"10.1016\/j.ejps.2025.107231_bib0030","doi-asserted-by":"crossref","first-page":"11578","DOI":"10.1073\/pnas.95.20.11578","article-title":"Reactivity of the HIV-1 nucleocapsid protein p7 zinc finger domains from the perspective of density-functional theory","volume":"95","author":"Maynard","year":"1998","journal-title":"Proceed. Nation. Acad. Sci. USA."},{"key":"10.1016\/j.ejps.2025.107231_bib0031","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1107\/S0021889898009856","article-title":"Rietveld refinement guidelines","volume":"32","author":"McCusker","year":"1999","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ejps.2025.107231_bib0032","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1063\/1.438980","article-title":"Contracted gaussian basis sets for molecular calculations. I. Second row atoms, Z=11\u201318","volume":"72","author":"McLean","year":"1980","journal-title":"J. Chemic. Phys."},{"key":"10.1016\/j.ejps.2025.107231_bib0033","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1017\/S0885715600010459","article-title":"Crystal pseudopolymorphism of secnidazole bulk drug, C7H11N3O3","volume":"14","author":"Novoa de Armas","year":"1999","journal-title":"Powder Diffr."},{"key":"10.1016\/j.ejps.2025.107231_bib0034","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1021\/acs.molpharmaceut.3c00947","article-title":"Preparation and characterization of a rifampicin coamorphous material with tromethamine coformer: an experimental\u2013Theoretical study","volume":"21","author":"Queiroz","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107231_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121500","article-title":"Structural, thermal, vibrational, solubility and DFT studies of a tolbutamide co-amorphous drug delivery system for treatment of diabetes","volume":"615","author":"R. S\u00e1","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107231_bib0036","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1021\/cg800587y","article-title":"Cocrystals and salts of Gabapentin: pH dependent cocrystal stability and solubility","volume":"9","author":"Reddy","year":"2009","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2025.107231_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2024.125057","article-title":"Molecular spectroscopy, solvent effect, and DFT studies of azithromycin solvate","volume":"325","author":"Rodrigues","year":"2025","journal-title":"Spectrochimica. Acta Part A."},{"key":"10.1016\/j.ejps.2025.107231_bib0038","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0022-3093(71)90053-6","article-title":"Relation between apparent glass transition temperature and liquids temperature for inorganic glasses","volume":"6","author":"Sakka","year":"1971","journal-title":"J. Non Cryst. Solid."},{"key":"10.1016\/j.ejps.2025.107231_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103863","article-title":"Recent advances in dual-drug co-amorphous systems","volume":"29","author":"Shelke","year":"2024","journal-title":"Drug. Discov. Today."},{"key":"10.1016\/j.ejps.2025.107231_bib0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.apsb.2018.08.002","article-title":"Advances in coamorphous drug delivery systems","volume":"9","author":"Shi","year":"2019","journal-title":"Acta Pharmaceutica Sinica B."},{"key":"10.1016\/j.ejps.2025.107231_bib0041","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/cryst7010013","article-title":"Ivabradine hydrochloride (S)-mandelic acid Co-crystal: in situ preparation during formulation","volume":"7","author":"Sl\u00e1dkov\u00e1","year":"2017","journal-title":"Crystals"},{"key":"10.1016\/j.ejps.2025.107231_bib0042","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1107\/S1600576721002910","article-title":"CrystalExplorer: a program for Hirshfeld surface analysis, visualization and quantitative analysis of molecular crystals","volume":"54","author":"Spackman","year":"2021","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ejps.2025.107231_bib0043","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1021\/acs.cgd.4c01558","article-title":"Innovative strategies in generic drug development: the role of polymorph, amorphous, pseudopolymorph, and cocrystal solid forms","volume":"25","author":"Suresh","year":"2025","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2025.107231_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140909","article-title":"Diastereoisomeric double salts of Carvedilol with (L)- and (D)-mandelic acids","volume":"1325","author":"Tenorio","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejps.2025.107231_bib0045","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1021\/acs.cgd.0c00654","article-title":"Crystalline multicomponent solids: an alternative for addressing the hygroscopicity issue in pharmaceutical materials","volume":"20","author":"Thakur","year":"2020","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2025.107231_bib0046","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1107\/S0021889801002242","article-title":"EXPGUI, a graphical user interface for GSAS","volume":"34","author":"Toby","year":"2001","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ejps.2025.107231_bib0047","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1021\/cr9904009","article-title":"Quantum mechanical continuum solvation models","volume":"105","author":"Tomasi","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejps.2025.107231_bib0048","series-title":"The dissolution procedure: development and validation","year":"2019"},{"key":"10.1016\/j.ejps.2025.107231_bib0049","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/chir.20834","article-title":"3, 3 0 -Diaryl-BINOL phosphoric acids as enantioselective extractants of benzylic primary amines","volume":"43","author":"Verkuijl","year":"2011","journal-title":"Chirality"},{"key":"10.1016\/j.ejps.2025.107231_bib0050","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1021\/cg800942n","article-title":"Piracetam Co-crystals with OH-group functionalized carboxylic acids","volume":"9","author":"Viertelhaus","year":"2009","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2025.107231_bib0051","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/bod.2510090106","article-title":"Types of mean residence times","volume":"9","author":"Wagner","year":"1988","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2025.107231_bib0052","doi-asserted-by":"crossref","first-page":"18981","DOI":"10.1021\/ja4103887","article-title":"Cocrystals of nicotinamide and (R)-mandelic acid in many ratios with anomalous formation properties","volume":"135","author":"Zhang","year":"2013","journal-title":"J. Am. Chem. Soc."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725002301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725002301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:57:19Z","timestamp":1778558239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725002301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":52,"alternative-id":["S0928098725002301"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107231","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation and characterization of a secnidazole-mandelic acid coamorphous system: enhanced dissolution profile, antibacterial properties, and theoretical druglikeness assessment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107231"}}